Pharmaceutical formulation comprising crystalline insulin and dissolved insulin
US7884181B2 · kind B2 · utility
0Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2005 |
| Grant date | Feb 8, 2011 |
| Priority date | — |
| Expiry date | Jul 6, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a pharmaceutical formulation and a method for preparing the formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.